Donation

Multiple myeloma care is rapidly evolving with new agents and combinations, new testing, and risk-adapted treatment strategies. Four highly experienced nurses will share their expertise during this 1.5 CNE symposium (3 sessions of 0.5 CNE) while using real-life patient case scenarios to focus on symptom management, infection control, and nursing implications. The participants can take part in a single session, two sessions, or the entire symposium. Free downloadable tools and resources are provided.

Available now, earn your CNE credits for these 3 activities!

Co-Chairs: Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; Joseph D. Tariman, PhD, RN, ANP-BC, FAAN
Faculty: Amy E. Pierre, RN, MSN, ANP-BC; Tiffany Richards, PhD, ANP-BC, AOCNP®


Part 1: Newly Diagnosed Multiple Myeloma
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN  
  
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity on newly diagnosed multiple myeloma will include an overview of the disease, as well as current treatment workup and testing recommendations for multiple myeloma. Through the cases of June and Lisa, our faculty will explore transplant eligibility, induction, and maintenance therapy. Please remember to complete part 2 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Begin, Earn Credit

 

CNE Part 1

Part 2: Relapsed Multiple Myeloma
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Amy E. Pierre, RN, MSN, ANP-BC
   
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity on relapsed multiple myeloma will include some recently approved drugs and dosage forms. Through the cases of Steve and Michelle, our faculty will review treatment considerations in the cases of early relapsed patients. Please remember to complete part 1 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Begin, Earn Credit

 

CNE Part 2

Part 3: Heavily Pretreated Multiple Myeloma and Drugs in Development
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Tiffany Richards, PhD, ANP-BC, AOCNP®
 
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity will focus on heavily pretreated multiple myeloma and drugs in development. Through the case of Carl, a patient who has received several multiple myeloma therapies over his 10-year history with the disease, our faculty will discuss clinical trial participation, and drugs in development. Please remember to complete part 1 and 2 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Begin, Earn Credit

 

CNE Part 3

Provided by the International Myeloma Foundation

Accredited by Annenberg Center for Health Sciences at Eisenhower

Supported by educational grants from Bristol Myers Squibb (formerly Celgene); GlaxoSmithKline; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics Inc.; Oncopeptides, Inc.; and Takeda Oncology.

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.